Unknown

Dataset Information

0

Post-transcriptional Regulation of BRCA2 through Interactions with miR-19a and miR-19b.


ABSTRACT: Breast cancer type 2, early onset susceptibility gene (BRCA2) is a major component of the homologous recombination DNA repair pathway. It acts as a tumor suppressor whose function is often lost in cancers. Patients with specific mutations in the BRCA2 gene often display discrete clinical, histopathological, and molecular features. However, a subset of sporadic cancers has wild type BRCA2 and display defects in the homology-directed repair pathway, which is the hallmark of 'BRCAness.' The mechanisms by which BRCAness arises are not well understood but post-transcriptional regulation of BRCA2 gene expression by microRNAs (miRNAs) may contribute to this phenotype. Here, we examine the post-transcriptional effects that some members of the six-miRNA cluster known as the miR-17/92 cluster have on the abundance of BRCA2's messenger RNA (mRNA) and protein. We discuss two interactions involving the miR-19a and miR-19b members of the cluster and the 3'UTR of BRCA2's mRNA. We investigated these miRNA:mRNA interactions in 15 cell lines derived from pancreatic, breast, colon, and kidney tissue. We show that over-expression of these two miRNAs results in a concomitant decrease of BRCA2's mRNA and protein expression in a subset of the tested cell lines. Additionally, using luciferase reporter assays we identified direct interactions between miR-19a/miR-19b and a miRNA response element (MRE) in BRCA2's 3'UTR. Our results suggest that BRCA2 is subject to a complex post-transcriptional regulatory program that has specific dependencies on the genetic and phenotypic background of cell types.

SUBMITTER: Mogilyansky E 

PROVIDER: S-EPMC5005319 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Post-transcriptional Regulation of BRCA2 through Interactions with miR-19a and miR-19b.

Mogilyansky Elena E   Clark Peter P   Quann Kevin K   Zhou Honglei H   Londin Eric E   Jing Yi Y   Rigoutsos Isidore I  

Frontiers in genetics 20160831


Breast cancer type 2, early onset susceptibility gene (BRCA2) is a major component of the homologous recombination DNA repair pathway. It acts as a tumor suppressor whose function is often lost in cancers. Patients with specific mutations in the BRCA2 gene often display discrete clinical, histopathological, and molecular features. However, a subset of sporadic cancers has wild type BRCA2 and display defects in the homology-directed repair pathway, which is the hallmark of 'BRCAness.' The mechani  ...[more]

Similar Datasets

| S-EPMC6470165 | biostudies-literature
| S-EPMC7064614 | biostudies-literature
| S-EPMC5445029 | biostudies-literature
| S-EPMC5996577 | biostudies-literature
| S-EPMC7425979 | biostudies-literature
| S-EPMC5711823 | biostudies-literature
| S-EPMC8282272 | biostudies-literature
| S-EPMC2857101 | biostudies-literature
| S-EPMC6226532 | biostudies-literature
| S-EPMC4513244 | biostudies-literature